A new study from the University of Chicago suggests that cholesterol-lowering statin drugs may improve survival of renal cell carcinoma. Statin drugs are known for their anti-inflammatory and self-destruction properties, which may lead to lowering the risk of developing certain types of cancer. According to study author Dr. Scott Eggener, associate professor of urologic oncology at the University of Chicago, "given that one in four Ameicans over 45 years of age take a statin and renal cell carcinoma occurs most often in men ages 50 to 70, it may be prudent to prospectively evaluate if statins protect against cancer progression."
To read more about this study, presented on May 7, 2013 at the annual meeting of the American Urological Association in San Diego, click here
No comments:
Post a Comment